Significant overall survival benefit with dostarlimab plus chemotherapy in advanced endometrial cancer.

Subjects

Subjects :

Humans
Female
Antibodies, Monoclonal, Humanized therapeutic use
Antibodies, Monoclonal, Humanized administration & dosage
Endometrial Neoplasms drug therapy
Endometrial Neoplasms mortality
Endometrial Neoplasms pathology
Antineoplastic Combined Chemotherapy Protocols therapeutic use

Details

Language :

English

ISSN :

1097-0142

Volume :

130

Issue :

13

Database :

MEDLINE

Journal :

Cancer

Publication Type :

Periodical

Accession number :

38849650

Full Text :

https://doi.org/10.1002/cncr.35372